134 related articles for article (PubMed ID: 36692404)
1. Separating the Benign from the Deadly: Active Surveillance of Oncocytoma after Biopsy.
Lockhart ME
Radiology; 2023 Apr; 307(2):e223108. PubMed ID: 36692404
[No Abstract] [Full Text] [Related]
2. Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe.
Richard PO; Jewett MA; Bhatt JR; Evans AJ; Timilsina N; Finelli A
J Urol; 2016 Mar; 195(3):581-6. PubMed ID: 26388501
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Biopsy of Renal Masses-When is it Necessary?
Derweesh IH
J Urol; 2016 Mar; 195(3):542-3. PubMed ID: 26694908
[No Abstract] [Full Text] [Related]
4. Renal oncocytoma: landscape of diagnosis and management.
Warren H; Neves JB; Tran MGB
BJU Int; 2021 Dec; 128(6):685-687. PubMed ID: 34036709
[No Abstract] [Full Text] [Related]
5. Editorial Comment.
Waingankar N; Uzzo RG
J Urol; 2016 Mar; 195(3):586-7. PubMed ID: 26655458
[No Abstract] [Full Text] [Related]
6. A Case of Renal Oncocytoma with Renal Venous Tumor Thrombus.
Kondo H; Okabe T; Okada Y; Hasebe T; Shirotake S; Oyama M; Nishimoto K
Keio J Med; 2019 Jun; 68(2):39-41. PubMed ID: 30473547
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
[TBL] [Abstract][Full Text] [Related]
8. A back-to-back tumor composed of papillary renal cell carcinoma and oncocytoma treated by laparoscopic partial nephrectomy: a case report.
Kang SH; Seo WT; Kang PM; Rhew HY; Jeon YH; Cheon BK; Kim TS
J Med Case Rep; 2018 May; 12(1):146. PubMed ID: 29779490
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy.
Srivastava A; Meyer AR; Pierorazio PM; Rowe SP; Allaf ME; Gorin MA
Clin Genitourin Cancer; 2018 Dec; 16(6):e1083-e1085. PubMed ID: 30097254
[No Abstract] [Full Text] [Related]
10. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
11. Giant renal oncocytoma.
Banks KL; Cherullo EE; Novick AC
Urology; 2001 Feb; 57(2):365. PubMed ID: 11182362
[TBL] [Abstract][Full Text] [Related]
12. Changing concepts in the management of renal oncocytoma.
Chao DH; Zisman A; Pantuck AJ; Freedland SJ; Said JW; Belldegrun AS
Urology; 2002 May; 59(5):635-42. PubMed ID: 11992832
[No Abstract] [Full Text] [Related]
13. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
14. 'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK:
Miller J; Campain N; Boydell AR; Warren H; Vito I; Neves J; Mumtaz F; Bex A; El-Shiekh S; Wagner T; Tran MGB
BJU Int; 2022 Jan; 129(1):28-31. PubMed ID: 34967994
[No Abstract] [Full Text] [Related]
15. [Bilateral multiple renal oncocytoma. Case report and review of the literature].
Villanueva Peña A; Roca Edreira A; De Diego Rodríguez E; Hernández Rodríguez R; Gutiérrez Baños JL; Aguilera Tubet C
Prog Urol; 2007 Sep; 17(5):997-9. PubMed ID: 17969806
[TBL] [Abstract][Full Text] [Related]
16. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
17. [Renal oncocytoma. Diagnosis and its therapeutic consequences].
Neisius D; Braedel HU; Steffens J; Moll V; Ziegler M
Urologe A; 1993 Sep; 32(5):415-9. PubMed ID: 8212428
[TBL] [Abstract][Full Text] [Related]
18. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report.
Pagano D; di Francesco F; Rosa L; Nwaiwu CA; Li Petri S; Gruttadauria S
World J Surg Oncol; 2018 Jul; 16(1):123. PubMed ID: 29966524
[TBL] [Abstract][Full Text] [Related]
19. Renal oncocytoma--are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis.
Haifler M; Copel L; Sandbank J; Lang E; Raz O; Leibovici D; Lindner A; Zisman A
Urol Oncol; 2012; 30(4):362-8. PubMed ID: 20171908
[TBL] [Abstract][Full Text] [Related]
20. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
